Literature DB >> 3923879

The pathogenesis of low glucose, low pH malignant effusions.

J T Good, D A Taryle, S A Sahn.   

Abstract

Possible mechanisms to explain the finding of a low pH, low glucose, malignant pleural effusion include: use of glucose and acid production by pleural fluid constituents including leukocytes and free malignant cells; pleural membrane metabolism, especially by malignant cells; abnormal transfer of glucose, carbon dioxide, and hydrogen ion across a diseased pleural membrane. To determine the pathogenesis of low glucose, low pH effusions, we performed incubation and glucose and gas transport studies in 5 patients with malignant effusions, 3 with a low pH (less than 7.30) and 2 with a pH greater than 7.30 (control patients). After 24 h of incubation, there was no significant difference in the metabolic activity of pleural fluid between low pH fluids and control fluids. Transport studies confirmed impaired glucose transfer both into and out of the pleural space and impaired efflux of CO2 from the pleural space in patients with low pH effusions, whereas control patients demonstrated free transfer across the pleural membrane. It appears that an abnormal pleural membrane (tumor or fibrosis), rather than increased acid production, results in a low glucose concentration from impaired glucose transfer from blood to pleural fluid and a low pH from impaired hydrogen ion efflux in some malignant effusions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923879     DOI: 10.1164/arrd.1985.131.5.737

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  A mature and fast-forming fibrous capsule using tetracycline: A preliminary report.

Authors:  Meltem Ayhan; Atilla Hacilar; Orgun Deren; Zeynep Aytug; Bülent Erdogan
Journal:  Can J Plast Surg       Date:  2004

2.  The diagnostic value of glucose in pleural/peritoneal fluid in tuberculosis.

Authors:  E G Wilkins
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

3.  Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases.

Authors:  Nobuaki Matsubara; Kuniaki Itoh; Hirofumi Mukai; Shunji Nagai
Journal:  Int J Clin Oncol       Date:  2011-10-07       Impact factor: 3.402

Review 4.  Malignant pleural effusions: appropriate treatment approaches.

Authors:  Yener Aydin; Atila Turkyilmaz; Yavuz Selim Intepe; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2009-12

Review 5.  Diagnosis and treatment of malignant pleural effusion.

Authors:  F H Hausheer; J W Yarbro
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Relationship of pleural fluid pH and glucose: a multi-centre study of 2,971 cases.

Authors:  Deirdre B Fitzgerald; Su Lyn Leong; Charley A Budgeon; Kevin Murray; Andrew Rosenstengal; Nicola A Smith; Silvia Bielsa; Amelia O Clive; Nick A Maskell; José M Porcel; Y C Gary Lee
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

7.  Prognostic Factors of 30-day Survival of Patients with Malignant Pleural Effusion.

Authors:  Zulkifli Amin; Stephen Diah Iskandar
Journal:  Indian J Palliat Care       Date:  2017 Jul-Sep

8.  Pleural Fluid Analysis in Chronic Hemothorax: A Mimicker of Infection.

Authors:  Matthew L DiVietro; John Terrill Huggins; Lauren Brown Angotti; Carlos E Kummerfeldt; Jennings E Nestor; Peter Doelken; Steven A Sahn
Journal:  Clin Med Insights Case Rep       Date:  2015-08-10

9.  Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.

Authors:  Antonia Marazioti; Chrysoula A Kairi; Magda Spella; Anastasios D Giannou; Sophia Magkouta; Ioanna Giopanou; Vassilios Papaleonidopoulos; Ioannis Kalomenidis; Linda A Snyder; Dimitrios Kardamakis; Georgios T Stathopoulos
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.